Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ELG Analysis of Glucose a Correlational to Blood Glucose Assa

NCT05055804 is registered in ClinicalTrials.gov with XP Technology, LLC as lead sponsor.

NCT NCT05055804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ELG Analysis of Glucose a Correlational to Blood Glucose Assa
Lead sponsor
XP Technology, LLC
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
August 11, 2021
Completion date
November 30, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diabetes mellitus, type 2